InvestorsHub Logo

gpb

Followers 2
Posts 52
Boards Moderated 0
Alias Born 12/21/2013

gpb

Re: flipper44 post# 3574

Thursday, 01/23/2014 9:27:03 PM

Thursday, January 23, 2014 9:27:03 PM

Post# of 704400
Bosch isn't the only interesting participant either - for example, it will be interesting to see if Bross (FDA) gives any unusual/fresh commentary on the selection of primary endpoints in the panel discussion (same session as the NWBO case study)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News